Network-1 Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Network-1 Technologies şirketinin toplam hissedar öz sermayesi $45.6M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $46.6M ve $1.0M dir.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	n/a
Nakit	US$41.52m
Eşitlik	US$45.58m
Toplam yükümlülükler	US$1.01m
Toplam varlıklar	US$46.59m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 6LK 'nin kısa vadeli varlıkları ( $41.7M ) kısa vadeli yükümlülüklerini ( $599.0K ) aşıyor.

Uzun Vadeli Yükümlülükler: 6LK şirketinin kısa vadeli varlıkları ( $41.7M ) uzun vadeli yükümlülüklerini ( $407.0K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 6LK borçsuzdur.

Borcun Azaltılması: 6LK son 5 yıldır borcu bulunmamaktadır.

Borç Kapsamı: 6LK un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: 6LK şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Network-1 Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

New minor risk - Share price stability

First half dividend of US$0.05 announced

Network-1 Technologies, Inc. Declares Semi-Annual Dividend, Payable on September 26, 2024

Second quarter 2024 earnings released: US$0.028 loss per share (vs US$0.02 loss in 2Q 2023)

Network-1 Technologies, Inc., Annual General Meeting, Sep 17, 2024

Upcoming dividend of US$0.05 per share

Dividend of US$0.05 announced

Network-1 Technologies, Inc. Declares Semi-Annual Dividend, Payable on March 29, 2024

Network-1 Technologies, Inc. Declares Semi-Annual Dividend, Payable on September 29, 2023

Network-1 Technologies, Inc. Reports First-Ever Demonstration of Protection Against B. Pertussis Colonization in Phase 2B Human Challenge Study of Bpzel Vaccine

Network-1 Technologies, Inc., Annual General Meeting, Sep 19, 2023

Network-1 Technologies, Inc. Announces Chief Financial Officer Changes

Insufficient new directors

Network-1 Technologies, Inc. Declares Semi-Annual Cash Dividend, Payable on September 30, 2022

First half 2022 earnings released: US$0.12 loss per share (vs US$0.36 profit in 1H 2021)

Network-1 Technologies, Inc., Annual General Meeting, Sep 20, 2022

First quarter 2022 earnings released: US$0.055 loss per share (vs US$0.39 profit in 1Q 2021)

Insufficient new directors

Full year 2021 earnings released: EPS: US$0.59 (vs US$0.071 loss in FY 2020)

Upcoming dividend of US$0.05 per share

Network-1 Technologies, Inc. Declares Semi-Annual Cash Dividend, Payable on March 24, 2022

Third quarter 2021 earnings released: EPS US$0.28 (vs US$0.07 in 3Q 2020)

Insider recently sold €456k worth of stock

First quarter 2021 earnings released: EPS US$0.39 (vs US$0.056 loss in 1Q 2020)

Insider recently sold €107k worth of stock

Full year 2020 earnings released: US$0.071 loss per share (vs US$0.075 loss in FY 2019)

Insider recently sold €88k worth of stock

New 90-day low: €2.48

Upcoming Dividend of US$0.05 Per Share

Insider recently sold €186k worth of stock

New 90-day high: €3.10

New 90-day high: €2.96

Insider recently sold €68k worth of stock

Insider recently sold €77k worth of stock

New 90-day high: €2.56

Insider recently sold €253k worth of stock

Third quarter 2020 earnings released: EPS US$0.07

New 90-day high: €2.50

Network-1 Technologies, Inc. Announces Court Overturns District Court Judgment of Non-Infringement in its Litigation with Hewlett-Packard

Iliad Biotechnologies, Llc Presented Positive Topline Phase 2B Trial Results of Its Lead Pertussis Vaccine

Insider recently sold €197k worth of stock

New 90-day high: €2.24

First half earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin